Abbott Molecular, Inc. recalls
2 notices naming Abbott Molecular, Inc. as the recalling firm, since April 30, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Abbott Molecular, Inc.: Alinity m Resp-4-Plex Amplification and 1 more
Hazard (FDA): There were reports of an increase in reactive negative controls and false positive results.
FDAMedical devices
Abbott Molecular, Inc.: The Alinity m System is designed to automate the steps for nucleic acid testing. Model…
Hazard (FDA): The design of the Alinity m System Solutions drawer enclosure may allow liquid (liquid waste or system solutions) originating in the System Solutions drawer to flow beyond the footprint of the instrument and into the…
FDAMedical devices